Rocket Pharmaceuticals: Leerink Partners cuts target price to $4 from $7
RCKT•Leerink Partners cut its target price for Rocket Pharmaceuticals to $4 from $7.
Related News
Enerflex Ltd.: BMO raises target price to C$48 from C$45
EFX•
Stryker Corporation: Truist Securities cuts target price to $310 from $340
SYK•
Devon Energy Corporation: Truist Securities cuts target price to $61 from $65
DVN•
Arrowhead says FDA grants plozasiran entry into STAR pilot program for severe hypertriglyceridemia sNDA
ARWR•
Atlantic Hpc Group appoints Leo Lin as chief executive officer
APUR•